Stocks360

Acasti Pharma Inc. (ACST.V)

Stock analysis · TSXV · Healthcare · Biotechnology

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
1.22
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

Acasti Pharma Inc. (ACST.V) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Jun 19, 2023
EPS $-0.37 vs est. $-0.16
Missed by $0.21

Proprietary Signals

Signal snapshot temporarily unavailable.

About Acasti Pharma Inc.

Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap